English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Editorial: Progress of programmed cell death in antitumor immunity Other
2023-01-01
Authors:  Yan FangFang;  Mao Chao;  Leung Elaine Lai Han;  Luo LianXiang
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date：2023/08/03
Cancer  Ferroptosis  Immune Checkpoint Inhibitors  Immunotherapy  Regulated Cell Death  Tumor Microenvironment  
S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung Journal article
Hao, Mengyao, Fu, Rong, Tai, Jun, Tian, Zhenhuan, Yuan, Xia, Chen, Yang, Wang, Mingjin, Jiang, Huimin, Ji, Ming, Lai, Fangfang, Xue, Nina, Bai, Liping, Zhu, Yizhun, Lv, Xiaoxi, Chen, Xiaoguang, Jin, Jing. S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung[J]. Acta Pharmaceutica Sinica B, 2022, 13(3), 1110-1127.
Authors:  Hao, Mengyao;  Fu, Rong;  Tai, Jun;  Tian, Zhenhuan;  Yuan, Xia; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:14.7/14.1 | Submit date：2023/01/30
Endothelial Barrier  Fty720  Idiopathic Pulmonary Fibrosis  Immh002  Protein Stability  Sphingosine-1-phosphate Receptor 1  Sphingosine-1-phosphate Receptor 1 Agonist  Tight Junction